The release of poor initial reviews for the Gal Gadot-led thriller "The Runner" appears to have triggered a significant sell-off in prediction markets for the similarly titled action film "Runner," starring Alan Ritchson, ahead of its September 11 release. In the September 01, 2026 session, contracts on the Kalshi exchange pricing a high critical score for the Ritchson film saw a sharp decline, with the probability of a Rotten Tomatoes score "Above 85" falling 77 percentage points to just 9%. The repricing suggests traders may be reacting to news about the wrong film, creating a stark reversal from previous optimism.
The market’s re-evaluation was broad, with most contracts pricing in lower odds for a high score. Seven of the ten available contracts declined on significant volume, indicating a widespread shift in expectations toward a more modest critical reception. The bulk of probability, once concentrated in the 80-90+ range, has now shifted to the 45-65 range, implying a much lower consensus for the film's final Tomatometer score.
Distribution Analysis
| Outcome | Current Prob | Change | Volume |
|---|---|---|---|
| Above 45 | 94% | +3.0pp | 10,779 |
| Above 50 | 88% | -1.0pp | 14,800 |
| Above 55 | 83% | -1.0pp | 6,878 |
| Above 60 | 72% | +27.0pp | 2,505 |
| Above 65 | 58% | +11.0pp | 1,608 |
| Above 70 | 41% | -11.0pp | 1,882 |
| Above 75 | 33% | -20.0pp | 747 |
| Above 80 | 24% | -70.0pp | 6,178 |
| Above 85 | 9% | -77.0pp | 11,279 |
| Above 90 | 3% | -40.0pp | 9,938 |
Net: 7 of 10 contracts declined on 51,702 total volume, shifting the implied consensus for the film's final score significantly lower.
What's Driving the Shift
- Apparent Name Confusion: The primary driver appears to be the release and negative critical reception of a different film, "The Runner," a psychological thriller starring Gal Gadot set for a streaming debut on September 2. Initial reviews for that film, which began appearing on September 1, were largely unfavorable, with publications like TheWrap calling it "not much of a thriller" and Screen Rant scoring it a 4/10. The timing of these reviews coincides directly with the sharp probability drop for the Alan Ritchson film, suggesting traders may have conflated the two similarly-titled projects.
- Contrasting Film Profiles: The two films are distinct projects from different studios. "Runner," starring Alan Ritchson and Owen Wilson, is an action-comedy being distributed theatrically by Angel Studios. In contrast, "The Runner" starring Gal Gadot is a psychological thriller being released directly to streaming by Prime Video. As of September 1, no critic reviews are available for the Ritchson film.
- Director's History: While the immediate trigger appears to be the case of mistaken identity, the market's willingness to sell off so sharply may be contextualized by the filmography of "Runner" director Scott Waugh. His previous action films have often received mixed to negative reviews, a factor that may have made traders more sensitive to any negative signals, even mistaken ones.
Market Context
Prior to this shift, the market was highly optimistic about "Runner," pricing the "Above 85" contract at 86%, implying near-certainty of a "Certified Fresh" rating. The sudden 77-point drop reflects a complete evaporation of that consensus. The move was heavily traded, with over 11,000 contracts changing hands in the "Above 85" market alone, underscoring the significance of the repricing. The probability that flowed out of the highest-rated tiers has primarily settled in the "Above 60" and "Above 65" contracts, which saw gains of 27 and 11 points, respectively. This suggests the new consensus is for a passable, but not exceptional, critical score.
What to Watch
The market will remain volatile until the review embargo for the correct film, "Runner," is lifted. The film is scheduled for a wide theatrical release on September 11, 2026, with official critic reviews expected to be published on its Rotten Tomatoes page in the days prior. A wave of positive reviews could cause an equally sharp reversal, while negative reviews would validate the market's current, more pessimistic pricing.
